Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-22-028155

Director acquired 35,406 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BUCHI J KEVIN Director 2022-05-08 Option exercise +35,406 105,491 D
Derivatives
BUCHI J KEVIN Director 2022-05-08 Option exercise · Restricted Stock Units −35,406 0 D
BUCHI J KEVIN Director 2022-05-09 Grant or award · Restricted Stock Units +80,128 80,128 D
Loading xslF345X03/doc4.xml…